Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells

FEIERSINGER, G., K. TRATTNIG, P. LEITNER, F. GUGGENBERGER, A. OBERHUBER, S. PEER, M. HERMANN, I. SKVORTSOVA, J. VRBKOVÁ, J. BOUCHAL, Z. CULIG, F. SANTER
Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells. Molecular Oncology. 2018, 12(4), 561-576, ISSN: 1574-7891, PMID: 29465803,